This study tests a new drug called IDX-1197 combined with standard chemotherapy (XELOX or irinotecan) in people with advanced stomach cancer. The goal is to find the safest dose and see if the combination helps control the cancer. About 87 adults with advanced or metastatic stoma…
Phase: PHASE1, PHASE2 • Sponsor: Idience Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC